Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by Cleave Biosciences Inc. View detailed product information, certifications, and sourcing options for each API. Connect with Cleave Biosciences Inc for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: U.S.A.
Supplier Description: Cleave Biosciences has a pipeline of novel, first-in-class therapeutics targeting protein-degradation pathways for difficult-to-treat cancers, supported by a deep understanding of the biology underlying these mechanisms. The company’s lead drug candidate, CB-5083, has entered clinical trials in patients with multiple myeloma and advanced solid tumors. Additional Cleave programs, which focus on AAA ATPases and novel zinc-dependent JAMM metalloproteases, remain in the discovery stage.
